MDxHealth Total Current Liabilities vs Total Stockholder Equity Analysis
MDXH Stock | USD 2.00 0.04 2.04% |
MDxHealth financial indicator trend analysis is infinitely more than just investigating MDxHealth SA ADR recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MDxHealth SA ADR is a good investment. Please check the relationship between MDxHealth Total Current Liabilities and its Total Stockholder Equity accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MDxHealth SA ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
Total Current Liabilities vs Total Stockholder Equity
Total Current Liabilities vs Total Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MDxHealth SA ADR Total Current Liabilities account and Total Stockholder Equity. At this time, the significance of the direction appears to have almost no relationship.
The correlation between MDxHealth's Total Current Liabilities and Total Stockholder Equity is 0.18. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of MDxHealth SA ADR, assuming nothing else is changed. The correlation between historical values of MDxHealth's Total Current Liabilities and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of MDxHealth SA ADR are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Total Current Liabilities i.e., MDxHealth's Total Current Liabilities and Total Stockholder Equity go up and down completely randomly.
Correlation Coefficient | 0.18 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Total Current Liabilities
Total Current Liabilities is an item on MDxHealth balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of MDxHealth SA ADR are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Most indicators from MDxHealth's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MDxHealth SA ADR current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MDxHealth SA ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. As of now, MDxHealth's Selling General Administrative is increasing as compared to previous years. The MDxHealth's current Tax Provision is estimated to increase to about 134.4 K, while Issuance Of Capital Stock is projected to decrease to under 39.3 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 1.9M | 6.1M | 5.6M | 5.9M | Depreciation And Amortization | 3.0M | 4.9M | 6.9M | 7.2M |
MDxHealth fundamental ratios Correlations
Click cells to compare fundamentals
MDxHealth Account Relationship Matchups
High Positive Relationship
High Negative Relationship
MDxHealth fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 40.6M | 31.9M | 75.1M | 119.1M | 129.1M | 135.6M | |
Short Long Term Debt Total | 11.0M | 15.9M | 15.6M | 39.8M | 41.3M | 43.3M | |
Other Current Liab | 909K | 4.1M | 3.7M | 6.3M | 8.6M | 9.0M | |
Total Current Liabilities | 10.4M | 13.0M | 16.4M | 18.3M | 19.5M | 10.0M | |
Total Stockholder Equity | 19.7M | 5.8M | 46.9M | 9.3M | 7.2M | 6.8M | |
Property Plant And Equipment Net | 2.5M | 3.7M | 5.0M | 7.9M | 9.9M | 10.4M | |
Net Debt | (11.0M) | (82K) | (42.9M) | 24.3M | 18.9M | 19.8M | |
Retained Earnings | (186.6M) | (215.3M) | (244.3M) | (288.3M) | (331.4M) | (314.9M) | |
Cash | 22.1M | 16.0M | 58.5M | 15.5M | 22.4M | 27.4M | |
Non Current Assets Total | 9.7M | 8.8M | 8.5M | 90.0M | 91.0M | 95.5M | |
Cash And Short Term Investments | 22.1M | 16.0M | 58.5M | 15.5M | 22.4M | 27.4M | |
Common Stock Shares Outstanding | 6.3M | 8.3M | 12.2M | 15.9M | 25.9M | 27.2M | |
Liabilities And Stockholders Equity | 40.6M | 31.9M | 75.1M | 119.1M | 129.1M | 135.6M | |
Non Current Liabilities Total | 10.5M | 13.0M | 11.7M | 91.5M | 102.4M | 107.5M | |
Other Stockholder Equity | 141.8M | 144.4M | 136.3M | 153.2M | 176.2M | 185.0M | |
Total Liab | 20.9M | 26.0M | 28.2M | 109.8M | 121.9M | 128.0M | |
Total Current Assets | 30.9M | 23.1M | 66.6M | 29.1M | 38.2M | 37.6M | |
Short Term Debt | 1.2M | 3.6M | 5.3M | 1.8M | 2.1M | 1.2M | |
Intangible Assets | 7.3M | 5.1M | 3.4M | 46.2M | 44.3M | 46.6M | |
Common Stock | 62.8M | 76.7M | 128.5M | 133.5M | 173.9M | 182.6M | |
Accounts Payable | 5.0M | 5.3M | 7.5M | 10.2M | 8.8M | 6.5M | |
Current Deferred Revenue | 3.3M | 3.2M | 2.7M | 472K | 424.8K | 403.6K | |
Net Receivables | 6.7M | 3.9M | 4.8M | 9.4M | 11.3M | 10.8M | |
Inventory | 1.2M | 2.3M | 1.9M | 2.3M | 2.8M | 1.7M | |
Accumulated Other Comprehensive Income | (918K) | (1.3M) | (1.0M) | (444K) | 11.5M | 12.1M | |
Net Tangible Assets | 12.5M | 791K | 43.5M | (72.8M) | (65.5M) | (62.2M) | |
Net Invested Capital | 29.3M | 18.9M | 59.0M | 44.8M | 43.4M | 45.8M | |
Net Working Capital | 20.5M | 10.1M | 50.2M | 10.9M | 18.6M | 19.8M | |
Property Plant Equipment | 2.5M | 3.7M | 5.0M | 7.9M | 9.1M | 9.5M | |
Long Term Debt | 9.1M | 10.3M | 7.7M | 34.9M | 35.6M | 17.9M | |
Capital Lease Obligations | 1.4M | 2.8M | 3.5M | 4.3M | 5.1M | 3.2M | |
Short Long Term Debt | 565K | 2.8M | 4.4M | 616K | 643K | 610.9K | |
Capital Stock | 62.8M | 76.7M | 128.5M | 133.5M | 173.9M | 115.4M |
Currently Active Assets on Macroaxis
When determining whether MDxHealth SA ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MDxHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mdxhealth Sa Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mdxhealth Sa Adr Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MDxHealth SA ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MDxHealth. If investors know MDxHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MDxHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.53) | Revenue Per Share 3.099 | Quarterly Revenue Growth 0.205 | Return On Assets (0.11) | Return On Equity (2.41) |
The market value of MDxHealth SA ADR is measured differently than its book value, which is the value of MDxHealth that is recorded on the company's balance sheet. Investors also form their own opinion of MDxHealth's value that differs from its market value or its book value, called intrinsic value, which is MDxHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MDxHealth's market value can be influenced by many factors that don't directly affect MDxHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MDxHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if MDxHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MDxHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.